LIDOCAINE 4%

LIDOCAINE 4% was reported 55197 times

LIDOCAINE 4% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 628 0.5913
1 INSPIRATORY CAPACITY DECREASED 88 0.3177
2 SLEEP DISORDER THERAPY 61 0.3081
3 APPENDICOLITH 89 0.2300
4 ANALGESIC THERAPY 61 0.1900
5 DRUG THERAPY 61 0.1799
6 TOXIC ANTERIOR SEGMENT SYNDROME 177 0.1622
7 MATERNAL EXPOSURE DURING DELIVERY 158 0.1594
8 INFUSION SITE DISCHARGE 220 0.1254
9 METHAEMOGLOBINAEMIA 251 0.1083
10 LAGOPHTHALMOS 43 0.1051
11 PRODUCT ADHESION ISSUE 3439 0.0962
12 INFUSION SITE MASS 98 0.0902
13 INFUSION SITE URTICARIA 60 0.0896
14 INFUSION SITE BRUISING 180 0.0833
15 INFUSION SITE PRURITUS 257 0.0814
16 INFUSION SITE HAEMORRHAGE 241 0.0732
17 CAUDA EQUINA SYNDROME 52 0.0677
18 INFUSION SITE RASH 84 0.0612
19 PROCEDURAL HYPOTENSION 52 0.0611
20 INFUSION SITE SWELLING 375 0.0595
21 ANAESTHETIC COMPLICATION NEUROLOGICAL 53 0.0585
22 ANAESTHETIC COMPLICATION 157 0.0584
23 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62 0.0584
24 INFUSION SITE DISCOMFORT 58 0.0559
25 INFUSION SITE NODULE 50 0.0520
26 KOUNIS SYNDROME 110 0.0484
27 INFUSION SITE WARMTH 59 0.0481
28 NEPHROGENIC ANAEMIA 212 0.0457
29 INFUSION SITE IRRITATION 57 0.0444
30 HYPERPARATHYROIDISM SECONDARY 111 0.0443
31 HYPERPHOSPHATAEMIA 95 0.0441
32 DEVICE INFUSION ISSUE 109 0.0439
33 APPLICATION SITE DISCOMFORT 78 0.0434
34 INFUSION SITE ERYTHEMA 366 0.0434
35 INFUSION SITE PAIN 549 0.0426
36 INCORRECT DRUG ADMINISTRATION RATE 178 0.0418
37 INFUSION SITE EXTRAVASATION 249 0.0400
38 HYPERTHERMIA MALIGNANT 58 0.0390
39 ADMINISTRATION SITE PAIN 44 0.0382
40 MULTIPLE ALLERGIES 295 0.0376
41 VASOPLEGIA SYNDROME 61 0.0372
42 RETINAL VASCULITIS 44 0.0369
43 INSURANCE ISSUE 535 0.0350
44 BLOOD PHOSPHORUS INCREASED 92 0.0337
45 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1767 0.0322
46 INFUSION SITE REACTION 91 0.0304
47 CORNEAL OEDEMA 68 0.0303
48 SEASONAL ALLERGY 419 0.0296
49 PULSELESS ELECTRICAL ACTIVITY 122 0.0292
50 TOTAL LUNG CAPACITY DECREASED 42 0.0263
51 REBOUND ACID HYPERSECRETION 78 0.0258
52 VENTRICULAR FIBRILLATION 279 0.0251
53 DERMATITIS CONTACT 285 0.0250
54 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 79 0.0238
55 PRODUCT QUALITY ISSUE 3191 0.0235
56 OBSTRUCTION 91 0.0228
57 RESPIRATORY TRACT INFECTION VIRAL 53 0.0227
58 STRESS CARDIOMYOPATHY 132 0.0227
59 LUNG OPACITY 57 0.0216
60 VENTRICULAR TACHYCARDIA 356 0.0215
61 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 133 0.0215
62 PARAPLEGIA 61 0.0211
63 IRON DEFICIENCY 94 0.0209
64 END STAGE RENAL DISEASE 379 0.0208
65 ANAPHYLACTIC SHOCK 522 0.0202
66 PULSE ABSENT 96 0.0202
67 POOR VENOUS ACCESS 205 0.0198
68 EAR INFECTION 522 0.0196
69 RESPIRATORY TRACT INFECTION 505 0.0194
70 SINUSITIS 1961 0.0191
71 CHRONIC SINUSITIS 71 0.0189
72 INGROWING NAIL 43 0.0182
73 TYPE I HYPERSENSITIVITY 64 0.0182
74 GENERALISED TONIC-CLONIC SEIZURE 293 0.0177
75 AORTIC STENOSIS 61 0.0175
76 VENTRICULAR HYPOKINESIA 56 0.0174
77 PRODUCT DISTRIBUTION ISSUE 161 0.0173
78 STATUS EPILEPTICUS 196 0.0173
79 CARDIOGENIC SHOCK 249 0.0173
80 RETINAL ARTERY OCCLUSION 43 0.0170
81 HYPOPHOSPHATAEMIA 125 0.0169
82 ANIMAL BITE 45 0.0169
83 UPPER RESPIRATORY TRACT INFECTION 771 0.0167
84 OTITIS MEDIA 55 0.0166
85 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 44 0.0165
86 LUMBAR SPINAL STENOSIS 48 0.0164
87 SKIN ABRASION 77 0.0163
88 APNOEA 126 0.0162
89 HAEMODYNAMIC INSTABILITY 123 0.0161
90 MYASTHENIA GRAVIS 130 0.0161
91 VASCULAR DEVICE INFECTION 73 0.0161
92 RHINOVIRUS INFECTION 62 0.0159
93 CATHETER SITE PAIN 41 0.0158
94 HYPERCAPNIA 47 0.0156
95 STREPTOCOCCAL INFECTION 86 0.0154
96 BLOOD URIC ACID INCREASED 89 0.0154
97 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 79 0.0154
98 DEAFNESS NEUROSENSORY 50 0.0152
99 BUNDLE BRANCH BLOCK LEFT 64 0.0151
100 VENTRICULAR ARRHYTHMIA 55 0.0150
101 SINUS TACHYCARDIA 212 0.0149
102 ANHEDONIA 392 0.0149
103 ARTHRITIS BACTERIAL 61 0.0148
104 SKIN INFECTION 165 0.0147
105 ANAPHYLACTIC REACTION 809 0.0146
106 RENAL INJURY 429 0.0144
107 STRIDOR 42 0.0143
108 GASTROENTERITIS VIRAL 250 0.0138
109 MULTI-ORGAN FAILURE 238 0.0138
110 ATELECTASIS 132 0.0136
111 TENDERNESS 142 0.0136
112 MENINGITIS ASEPTIC 61 0.0136
113 APPENDICITIS 126 0.0135
114 PHARYNGITIS STREPTOCOCCAL 145 0.0134
115 PROCTALGIA 86 0.0134
116 BRONCHIECTASIS 90 0.0133
117 SPINAL CORD COMPRESSION 52 0.0133
118 PARADOXICAL DRUG REACTION 49 0.0133
119 FEAR 358 0.0133
120 SPINAL OSTEOARTHRITIS 116 0.0132
121 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 66 0.0130
122 VENTRICULAR EXTRASYSTOLES 135 0.0130
123 INTERVERTEBRAL DISC DEGENERATION 120 0.0130
124 ENDOPHTHALMITIS 77 0.0128
125 RESPIRATORY ACIDOSIS 50 0.0127
126 SKIN LACERATION 138 0.0127
127 RESPIRATORY DEPRESSION 154 0.0126
128 TOOTH INFECTION 164 0.0124
129 HYPOXIA 432 0.0123
130 PRODUCT ADMINISTRATION INTERRUPTED 96 0.0122
131 UNRESPONSIVE TO STIMULI 315 0.0122
132 CARDIAC ARREST 998 0.0121
133 LIVE BIRTH 101 0.0121
134 BACTERIAL INFECTION 225 0.0120
135 NYSTAGMUS 64 0.0120
136 GASTROINTESTINAL INFECTION 108 0.0120
137 SINUS BRADYCARDIA 113 0.0117
138 BRONCHITIS 864 0.0117
139 ARTHRITIS INFECTIVE 54 0.0116
140 HORDEOLUM 50 0.0115
141 DECUBITUS ULCER 94 0.0115
142 NEURALGIA 279 0.0115
143 BRADYCARDIA 608 0.0115
144 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 195 0.0114
145 BREATH SOUNDS ABNORMAL 56 0.0113
146 TROPONIN INCREASED 86 0.0113
147 NEUROTOXICITY 197 0.0112
148 HYPERLIPIDAEMIA 134 0.0112
149 SINUS DISORDER 222 0.0112
150 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 99 0.0112
151 KIDNEY INFECTION 219 0.0111
152 RESPIRATORY SYNCYTIAL VIRUS INFECTION 97 0.0111
153 CHRONIC KIDNEY DISEASE 843 0.0111
154 BRAIN OEDEMA 139 0.0110
155 TORSADE DE POINTES 86 0.0110
156 PSEUDOMONAS INFECTION 94 0.0110
157 SENSORY LOSS 88 0.0109
158 PNEUMONIA FUNGAL 43 0.0109
159 VIRAL INFECTION 361 0.0108
160 MYDRIASIS 138 0.0107
161 POST PROCEDURAL INFECTION 87 0.0107
162 MENTAL STATUS CHANGES 296 0.0106
163 GLUCOSE TOLERANCE IMPAIRED 63 0.0106
164 EYE INFECTION 120 0.0106
165 POST PROCEDURAL COMPLICATION 204 0.0106
166 HYPERVOLAEMIA 52 0.0105
167 WEIGHT FLUCTUATION 110 0.0105
168 PERIPHERAL VASCULAR DISORDER 54 0.0105
169 PRE-EXISTING CONDITION IMPROVED 65 0.0104
170 BRONCHOSPASM 148 0.0104
171 NORMAL NEWBORN 56 0.0103
172 FOOD POISONING 55 0.0103
173 CANDIDA INFECTION 173 0.0102
174 TOOTH ABSCESS 104 0.0102
175 STAPHYLOCOCCAL INFECTION 336 0.0102
176 PROCEDURAL COMPLICATION 78 0.0102
177 PHARYNGITIS 125 0.0101
178 IMMUNE THROMBOCYTOPENIA 46 0.0100
179 CIRCULATORY COLLAPSE 171 0.0100
180 MYOCLONUS 119 0.0100
181 CONCUSSION 77 0.0099
182 HEPARIN-INDUCED THROMBOCYTOPENIA 49 0.0099
183 INFUSION RELATED REACTION 658 0.0099
184 RHINITIS ALLERGIC 44 0.0099
185 LEFT VENTRICULAR DYSFUNCTION 66 0.0098
186 HYPOAESTHESIA ORAL 148 0.0098
187 RALES 57 0.0098
188 MENINGITIS 65 0.0097
189 APPLICATION SITE RASH 133 0.0097
190 CYSTITIS 307 0.0096
191 SKIN NECROSIS 50 0.0096
192 LOCALISED INFECTION 233 0.0096
193 VARICOSE VEIN 49 0.0095
194 CARDIOTOXICITY 84 0.0094
195 DIVERTICULUM INTESTINAL 41 0.0094
196 RIB FRACTURE 192 0.0093
197 NERVE INJURY 103 0.0093
198 ESCHERICHIA INFECTION 76 0.0092
199 ARTHROPOD BITE 68 0.0092
200 BODY HEIGHT DECREASED 98 0.0092
201 ACUTE RESPIRATORY FAILURE 176 0.0091
202 STAPHYLOCOCCAL SEPSIS 45 0.0091
203 FOOD ALLERGY 70 0.0091
204 RENAL FAILURE 1199 0.0090
205 ATRIOVENTRICULAR BLOCK COMPLETE 60 0.0090
206 URINARY TRACT INFECTION 1527 0.0089
207 SCIATICA 142 0.0089
208 SPINAL COLUMN STENOSIS 42 0.0089
209 INJURY 625 0.0089
210 HYPERAESTHESIA 73 0.0089
211 ECONOMIC PROBLEM 134 0.0088
212 ROTATOR CUFF SYNDROME 113 0.0088
213 SUPRAVENTRICULAR TACHYCARDIA 84 0.0088
214 RENAL TUBULAR NECROSIS 86 0.0088
215 CELLULITIS 440 0.0087
216 ACUTE PULMONARY OEDEMA 49 0.0087
217 LIGAMENT SPRAIN 86 0.0087
218 APPLICATION SITE PAIN 190 0.0086
219 APPLICATION SITE IRRITATION 107 0.0086
220 IMPAIRED GASTRIC EMPTYING 117 0.0086
221 FIBROMYALGIA 208 0.0085
222 MIOSIS 68 0.0085
223 INABILITY TO AFFORD MEDICATION 84 0.0084
224 MUSCLE STRAIN 73 0.0084
225 SCAR 144 0.0084
226 HAEMORRHOIDS 164 0.0084
227 FACIAL PAIN 75 0.0084
228 LYMPHOEDEMA 58 0.0084
229 COVID-19 PNEUMONIA 99 0.0084
230 LIMB INJURY 227 0.0083
231 GINGIVITIS 45 0.0083
232 NERVE COMPRESSION 77 0.0083
233 GRAND MAL CONVULSION 77 0.0083
234 MUSCULOSKELETAL CHEST PAIN 129 0.0083
235 PRODUCTIVE COUGH 396 0.0083
236 HYPOTENSION 1656 0.0082
237 INADEQUATE ANALGESIA 70 0.0082
238 EXOSTOSIS 75 0.0082
239 ORAL CANDIDIASIS 108 0.0082
240 ILLNESS 838 0.0081
241 BEHAVIOUR DISORDER 44 0.0081
242 BENIGN PROSTATIC HYPERPLASIA 42 0.0081
243 HIATUS HERNIA 105 0.0081
244 FACIAL PARALYSIS 69 0.0081
245 TACHYPNOEA 110 0.0081
246 FAILURE TO THRIVE 42 0.0081
247 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 44 0.0081
248 ECCHYMOSIS 55 0.0080
249 IRON DEFICIENCY ANAEMIA 74 0.0080
250 COVID-19 1404 0.0080
251 POSTOPERATIVE WOUND INFECTION 54 0.0080
252 RESPIRATORY TRACT CONGESTION 127 0.0080
253 DRUG LEVEL INCREASED 132 0.0080
254 CLOSTRIDIUM DIFFICILE COLITIS 84 0.0079
255 FOOT FRACTURE 150 0.0079
256 UPPER-AIRWAY COUGH SYNDROME 65 0.0079
257 SPINAL OPERATION 97 0.0079
258 SPINAL PAIN 92 0.0078
259 VITREOUS FLOATERS 77 0.0078
260 THERAPY PARTIAL RESPONDER 122 0.0078
261 INJECTION SITE DISCHARGE 42 0.0078
262 RENAL CYST 62 0.0078
263 HYPERKERATOSIS 43 0.0078
264 OSTEOMYELITIS 141 0.0078
265 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 406 0.0078
266 SKIN WARM 45 0.0077
267 TACHYCARDIA 687 0.0077
268 MULTIPLE ORGAN DYSFUNCTION SYNDROME 218 0.0077
269 ANAL INCONTINENCE 69 0.0077
270 COMPRESSION FRACTURE 41 0.0076
271 SLEEP APNOEA SYNDROME 146 0.0076
272 FEBRILE NEUTROPENIA 505 0.0076
273 PRODUCT AVAILABILITY ISSUE 172 0.0075
274 TOXICITY TO VARIOUS AGENTS 1273 0.0075
275 JOINT EFFUSION 52 0.0075
276 HAND FRACTURE 53 0.0075
277 DIPLOPIA 194 0.0075
278 SENSITIVE SKIN 55 0.0074
279 RETINAL HAEMORRHAGE 53 0.0074
280 CYANOSIS 117 0.0074
281 CARPAL TUNNEL SYNDROME 104 0.0074
282 PARAESTHESIA ORAL 107 0.0074
283 SINUS CONGESTION 100 0.0074
284 AUTOIMMUNE DISORDER 72 0.0074
285 EYELID PTOSIS 75 0.0074
286 OSTEOPENIA 112 0.0074
287 SPINAL COMPRESSION FRACTURE 61 0.0074
288 ULCER 117 0.0073
289 OXYGEN SATURATION DECREASED 412 0.0073
290 INCONTINENCE 77 0.0073
291 VITAMIN D DEFICIENCY 71 0.0073
292 INTERVERTEBRAL DISC PROTRUSION 159 0.0073
293 FLANK PAIN 68 0.0072
294 CARDIOMEGALY 89 0.0072
295 UNEVALUABLE EVENT 545 0.0072
296 OBSTRUCTIVE AIRWAYS DISORDER 80 0.0072
297 PNEUMOTHORAX 114 0.0072
298 RESPIRATORY DISTRESS 198 0.0072
299 MASS 100 0.0071
300 GOUT 128 0.0071
301 ASPIRATION 78 0.0071
302 DRUG TOXICITY 97 0.0071
303 BLOOD CALCIUM INCREASED 62 0.0071
304 BODY TEMPERATURE INCREASED 144 0.0071
305 NECK PAIN 394 0.0070
306 DYSARTHRIA 264 0.0070
307 POST-TRAUMATIC STRESS DISORDER 47 0.0070
308 BURSITIS 85 0.0070
309 ENCEPHALOPATHY 172 0.0070
310 JOINT DISLOCATION 74 0.0070
311 HEREDITARY ANGIOEDEMA 75 0.0070
312 SMALL INTESTINAL OBSTRUCTION 86 0.0070
313 SEROTONIN SYNDROME 132 0.0069
314 PNEUMONIA BACTERIAL 63 0.0069
315 SPINAL DISORDER 65 0.0069
316 PREMATURE DELIVERY 109 0.0068
317 WALKING AID USER 45 0.0068
318 IMPAIRED QUALITY OF LIFE 98 0.0068
319 WRONG PRODUCT ADMINISTERED 46 0.0068
320 SEPSIS 754 0.0068
321 WOUND INFECTION 74 0.0068
322 FUNGAL INFECTION 225 0.0067
323 MALNUTRITION 75 0.0067
324 BRAIN FOG 105 0.0067
325 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 52 0.0067
326 ORAL DISORDER 49 0.0067
327 PULMONARY MASS 99 0.0066
328 HYPERCHOLESTEROLAEMIA 64 0.0066
329 MUSCULOSKELETAL DISCOMFORT 114 0.0066
330 BACTERAEMIA 78 0.0066
331 PNEUMONIA ASPIRATION 164 0.0066
332 THERAPY NON-RESPONDER 295 0.0066
333 HERPES ZOSTER 377 0.0066
334 PULMONARY OEDEMA 293 0.0065
335 PHARYNGEAL SWELLING 64 0.0065
336 DIVERTICULUM 46 0.0065
337 JOINT INJURY 138 0.0065
338 LUNG INFILTRATION 57 0.0064
339 MIGRAINE 616 0.0064
340 PULMONARY CONGESTION 85 0.0064
341 HYPOALBUMINAEMIA 50 0.0064
342 NEPHROPATHY 60 0.0064
343 PNEUMONIA 2080 0.0064
344 DIVERTICULITIS 178 0.0064
345 INFLUENZA 716 0.0064
346 TRICUSPID VALVE INCOMPETENCE 51 0.0064
347 OEDEMA 348 0.0064
348 CLOSTRIDIUM DIFFICILE INFECTION 140 0.0064
349 POOR QUALITY SLEEP 138 0.0064
350 DELIRIUM 222 0.0064
351 BLOOD PRESSURE ABNORMAL 127 0.0064
352 RESPIRATION ABNORMAL 44 0.0064
353 BRAIN INJURY 64 0.0064
354 MOTOR DYSFUNCTION 65 0.0064
355 ACCIDENT 76 0.0064
356 PLEURAL EFFUSION 387 0.0064
357 THERMAL BURN 45 0.0063
358 APPLICATION SITE ERYTHEMA 166 0.0063
359 SPUTUM DISCOLOURED 60 0.0063
360 RHINITIS 51 0.0063
361 APPLICATION SITE VESICLES 41 0.0063
362 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1137 0.0063
363 RESPIRATORY FAILURE 460 0.0063
364 EXTRASYSTOLES 44 0.0063
365 CONTUSION 605 0.0063
366 RESPIRATORY ARREST 173 0.0063
367 SHOCK 144 0.0063
368 BACK INJURY 68 0.0062
369 BLOOD PRESSURE DECREASED 415 0.0062
370 CARDIO-RESPIRATORY ARREST 260 0.0062
371 ORAL PAIN 139 0.0062
372 UROSEPSIS 57 0.0062
373 HAEMATOCRIT DECREASED 122 0.0061
374 PARALYSIS 88 0.0061
375 ANKLE FRACTURE 95 0.0061
376 EAR PAIN 119 0.0061
377 PRODUCT DOSE OMISSION ISSUE 1797 0.0061
378 SPINAL FRACTURE 122 0.0061
379 CYTOKINE RELEASE SYNDROME 122 0.0061
380 HOSPICE CARE 60 0.0061
381 ACUTE KIDNEY INJURY 928 0.0061
382 BLOOD ALBUMIN DECREASED 48 0.0060
383 BACK DISORDER 98 0.0060
384 ASCITES 177 0.0060
385 BACK PAIN 1397 0.0060
386 MITRAL VALVE INCOMPETENCE 68 0.0060
387 SKIN ULCER 155 0.0060
388 NEPHROLITHIASIS 275 0.0060
389 RIGHT VENTRICULAR FAILURE 42 0.0060
390 EYE MOVEMENT DISORDER 41 0.0060
391 PROCEDURAL PAIN 166 0.0060
392 ATAXIA 71 0.0060
393 PAPULE 42 0.0060
394 MICTURITION URGENCY 68 0.0059
395 EMPHYSEMA 60 0.0059
396 NASOPHARYNGITIS 1096 0.0059
397 BLADDER DISORDER 59 0.0059
398 APHTHOUS ULCER 46 0.0059
399 LOW BIRTH WEIGHT BABY 47 0.0059
400 METABOLIC ACIDOSIS 189 0.0059
401 PELVIC FRACTURE 46 0.0059
402 PULMONARY HYPERTENSION 123 0.0059
403 ELECTROCARDIOGRAM QT PROLONGED 211 0.0059
404 LEUKOCYTOSIS 106 0.0059
405 SEIZURE 675 0.0058
406 DYSPNOEA EXERTIONAL 220 0.0058
407 NODULE 76 0.0058
408 JOINT RANGE OF MOTION DECREASED 78 0.0058
409 APHONIA 81 0.0058
410 OSTEOPOROSIS 238 0.0058
411 OSTEOARTHRITIS 245 0.0058
412 CONJUNCTIVITIS 107 0.0058
413 DISABILITY 114 0.0058
414 INFECTION 834 0.0058
415 RENAL FAILURE CHRONIC 44 0.0057
416 DENTAL CARIES 63 0.0057
417 GROIN PAIN 50 0.0057
418 ATRIOVENTRICULAR BLOCK 44 0.0057
419 BLOOD PRESSURE DIASTOLIC DECREASED 42 0.0057
420 TOOTHACHE 103 0.0057
421 PREMATURE BABY 171 0.0057
422 CHILLS 664 0.0057
423 DEPRESSED LEVEL OF CONSCIOUSNESS 224 0.0057
424 DEVICE RELATED INFECTION 87 0.0056
425 PAIN 3465 0.0056
426 RESPIRATORY DISORDER 168 0.0056
427 PAIN IN JAW 159 0.0056
428 HYDRONEPHROSIS 42 0.0056
429 SWELLING 525 0.0056
430 BLINDNESS TRANSIENT 41 0.0056
431 EJECTION FRACTION DECREASED 86 0.0055
432 ORAL HERPES 108 0.0055
433 TOOTH DISORDER 123 0.0055
434 ARTERIOSCLEROSIS 52 0.0055
435 MUSCLE RIGIDITY 66 0.0055
436 ABSCESS 88 0.0055
437 ATRIAL FLUTTER 44 0.0055
438 HYPERTHERMIA 42 0.0055
439 HEAD INJURY 174 0.0055
440 ATRIAL FIBRILLATION 534 0.0055
441 DIZZINESS POSTURAL 53 0.0055
442 BLOOD MAGNESIUM DECREASED 47 0.0054
443 WRIST FRACTURE 65 0.0054
444 RENAL FAILURE ACUTE 230 0.0054
445 FALL 1801 0.0054
446 HYPOKALAEMIA 249 0.0054
447 GASTROOESOPHAGEAL REFLUX DISEASE 434 0.0054
448 TUBULOINTERSTITIAL NEPHRITIS 101 0.0054
449 LOWER RESPIRATORY TRACT INFECTION 245 0.0054
450 HEMIPARESIS 91 0.0054
451 HEART RATE DECREASED 188 0.0053
452 LETHARGY 307 0.0053
453 MUSCLE TWITCHING 123 0.0053
454 APPLICATION SITE PRURITUS 121 0.0053
455 EXPIRED PRODUCT ADMINISTERED 177 0.0053
456 ACUTE CORONARY SYNDROME 44 0.0053
457 PURPURA 47 0.0053
458 ILEUS 66 0.0053
459 BLOOD IRON DECREASED 63 0.0053
460 BLOOD POTASSIUM DECREASED 159 0.0053
461 LOSS OF CONSCIOUSNESS 677 0.0053
462 SUBSTANCE ABUSE 43 0.0053
463 OROPHARYNGEAL PAIN 489 0.0053
464 ANXIETY 1500 0.0053
465 UPPER LIMB FRACTURE 105 0.0053
466 BLOOD UREA INCREASED 88 0.0053
467 ELECTROLYTE IMBALANCE 61 0.0052
468 MUSCLE TIGHTNESS 85 0.0052
469 PULMONARY THROMBOSIS 57 0.0052
470 IRRITABLE BOWEL SYNDROME 112 0.0052
471 HEPATOMEGALY 51 0.0052
472 MYOCARDIAL ISCHAEMIA 59 0.0052
473 INCORRECT PRODUCT ADMINISTRATION DURATION 112 0.0052
474 URINARY INCONTINENCE 153 0.0052
475 FOOT DEFORMITY 57 0.0051
476 CARDIOMYOPATHY 76 0.0051
477 HYPERTENSIVE CRISIS 57 0.0051
478 RETINAL DETACHMENT 47 0.0051
479 HYPOMAGNESAEMIA 71 0.0051
480 OROPHARYNGEAL DISCOMFORT 46 0.0051
481 NEUTROPHIL COUNT INCREASED 52 0.0051
482 PYELONEPHRITIS 44 0.0051
483 CYST 63 0.0051
484 INTENTIONAL PRODUCT USE ISSUE 444 0.0051
485 POST PROCEDURAL HAEMORRHAGE 59 0.0051
486 DRUG INTERACTION 803 0.0051
487 HYPONATRAEMIA 285 0.0051
488 HAEMATOMA 131 0.0051
489 BONE DISORDER 92 0.0050
490 STOMATITIS 306 0.0050
491 CATARACT 300 0.0050
492 URINARY RETENTION 168 0.0050
493 SCRATCH 53 0.0050
494 PRODUCT USE IN UNAPPROVED INDICATION 1245 0.0050
495 MYOSITIS 45 0.0050
496 ACCIDENTAL OVERDOSE 183 0.0050
497 BLOOD PRESSURE INCREASED 762 0.0050
498 BLOOD CALCIUM DECREASED 56 0.0050
499 NEUROPATHY PERIPHERAL 473 0.0050
500 PALLOR 135 0.0050
501 RESPIRATORY RATE INCREASED 44 0.0050
502 DISCOMFORT 302 0.0049
503 LYMPHADENOPATHY 175 0.0049
504 OESOPHAGITIS 54 0.0049
505 GENERALISED OEDEMA 61 0.0049
506 EMOTIONAL DISTRESS 595 0.0049
507 LIMB DISCOMFORT 152 0.0049
508 HAEMOPTYSIS 137 0.0049
509 HYPERTENSION 1039 0.0049
510 ROAD TRAFFIC ACCIDENT 205 0.0049
511 TOOTH FRACTURE 54 0.0049
512 PHOTOPHOBIA 92 0.0049
513 COUGH 1368 0.0049
514 TINNITUS 224 0.0049
515 PYREXIA 1684 0.0049
516 COMA 231 0.0048
517 HYPERKALAEMIA 170 0.0048
518 BLOOD TEST ABNORMAL 68 0.0048
519 NASAL CONGESTION 284 0.0048
520 HALLUCINATION, VISUAL 102 0.0048
521 COLD SWEAT 85 0.0048
522 EYE INFLAMMATION 46 0.0048
523 SUBARACHNOID HAEMORRHAGE 49 0.0048
524 LYMPHOCYTE COUNT DECREASED 85 0.0048
525 HYPOTONIA 48 0.0048
526 BASAL CELL CARCINOMA 75 0.0048
527 RESTLESS LEGS SYNDROME 87 0.0048
528 PRESYNCOPE 116 0.0048
529 DISSEMINATED INTRAVASCULAR COAGULATION 67 0.0048
530 MUCOSAL INFLAMMATION 124 0.0047
531 OCULAR DISCOMFORT 53 0.0047
532 OFF LABEL USE 4118 0.0047
533 QUALITY OF LIFE DECREASED 63 0.0047
534 DERMATITIS ALLERGIC 59 0.0047
535 SEPTIC SHOCK 204 0.0047
536 WHEEZING 278 0.0047
537 HEADACHE 2936 0.0047
538 TOXIC EPIDERMAL NECROLYSIS 71 0.0047
539 INCREASED TENDENCY TO BRUISE 43 0.0047
540 CONSTIPATION 1015 0.0046
541 EXPOSURE DURING PREGNANCY 289 0.0046
542 BLOOD URINE PRESENT 88 0.0046
543 RENAL PAIN 49 0.0046
544 BLOOD SODIUM DECREASED 87 0.0046
545 LIVER FUNCTION TEST INCREASED 99 0.0046
546 HERNIA 89 0.0046
547 ANGIOEDEMA 203 0.0046
548 DEHYDRATION 612 0.0046
549 WOUND 128 0.0046
550 HEART RATE INCREASED 453 0.0046
551 RENAL IMPAIRMENT 384 0.0046
552 HYPOAESTHESIA 683 0.0046
553 RESTLESSNESS 167 0.0046
554 COAGULOPATHY 76 0.0046
555 ABDOMINAL DISTENSION 475 0.0045
556 LOWER LIMB FRACTURE 87 0.0045
557 NEOPLASM 52 0.0045
558 CHROMATURIA 102 0.0045
559 GASTROINTESTINAL DISORDER 404 0.0045
560 APHASIA 136 0.0045
561 BLOOD CHOLESTEROL INCREASED 209 0.0045
562 DYSURIA 165 0.0045
563 HYPOTHYROIDISM 143 0.0045
564 COMPLICATION ASSOCIATED WITH DEVICE 65 0.0045
565 BURNING SENSATION 313 0.0045
566 INTRAOCULAR PRESSURE INCREASED 57 0.0045
567 PERIPHERAL SWELLING 686 0.0044
568 FULL BLOOD COUNT ABNORMAL 47 0.0044
569 FLUID RETENTION 226 0.0044
570 MATERNAL EXPOSURE DURING PREGNANCY 396 0.0044
571 THROMBOSIS 357 0.0044
572 ARTHRITIS 349 0.0044
573 CONFUSIONAL STATE 716 0.0044
574 SWOLLEN TONGUE 138 0.0044
575 ERYTHEMA MULTIFORME 41 0.0044
576 VISUAL ACUITY REDUCED 146 0.0044
577 DEFORMITY 41 0.0044
578 HEART RATE IRREGULAR 99 0.0044
579 RED BLOOD CELL COUNT DECREASED 125 0.0044
580 CHEST PAIN 809 0.0044
581 MOUTH ULCERATION 92 0.0044
582 ACUTE RESPIRATORY DISTRESS SYNDROME 77 0.0043
583 SKIN DISCOLOURATION 200 0.0043
584 DRY MOUTH 353 0.0043
585 SOMNOLENCE 875 0.0043
586 EYE PAIN 245 0.0043
587 MUSCULAR WEAKNESS 493 0.0043
588 EYE DISCHARGE 45 0.0043
589 DYSTONIA 84 0.0043
590 MUSCULOSKELETAL PAIN 226 0.0043
591 INFLUENZA LIKE ILLNESS 355 0.0043
592 ASTHMA 487 0.0043
593 EPISTAXIS 322 0.0043
594 CHEST DISCOMFORT 440 0.0043
595 TRANSFUSION 45 0.0043
596 NERVOUS SYSTEM DISORDER 134 0.0043
597 WEIGHT DECREASED 1195 0.0043
598 SLEEP DISORDER 302 0.0043
599 SPEECH DISORDER 224 0.0043
600 IMPAIRED HEALING 140 0.0043
601 TASTE DISORDER 86 0.0042
602 DYSPHAGIA 402 0.0042
603 ANAEMIA 807 0.0042
604 EATING DISORDER 90 0.0042
605 NEEDLE ISSUE 123 0.0042
606 COLITIS 160 0.0042
607 VERTIGO 257 0.0042
608 TENDON RUPTURE 52 0.0042
609 OEDEMA PERIPHERAL 513 0.0042
610 AGITATION 309 0.0042
611 GLAUCOMA 81 0.0042
612 ARRHYTHMIA 199 0.0042
613 TENDONITIS 65 0.0042
614 SKIN DISORDER 140 0.0042
615 WHITE BLOOD CELL COUNT INCREASED 161 0.0042
616 SYNCOPE 418 0.0042
617 LIP SWELLING 139 0.0042
618 SARS-COV-2 TEST POSITIVE 55 0.0042
619 DYSPHONIA 243 0.0042
620 PULMONARY EMBOLISM 394 0.0041
621 ACUTE MYOCARDIAL INFARCTION 122 0.0041
622 PAIN IN EXTREMITY 1218 0.0041
623 NIGHT SWEATS 133 0.0041
624 DEVICE OCCLUSION 58 0.0041
625 VOMITING 1936 0.0041
626 MACULAR DEGENERATION 49 0.0041
627 FATIGUE 3190 0.0041
628 EAR DISCOMFORT 42 0.0041
629 GALLBLADDER DISORDER 73 0.0041
630 BLOOD PRESSURE FLUCTUATION 98 0.0041
631 RETCHING 87 0.0041
632 SECRETION DISCHARGE 51 0.0041
633 MUSCLE SPASTICITY 50 0.0041
634 BLOOD POTASSIUM INCREASED 66 0.0041
635 TREMOR 674 0.0041
636 LUNG DISORDER 199 0.0041
637 DYSKINESIA 165 0.0041
638 FEELING COLD 113 0.0041
639 PRODUCT USE ISSUE 758 0.0040
640 SCAB 46 0.0040
641 PETECHIAE 42 0.0040
642 BLISTER 226 0.0040
643 NAUSEA 3183 0.0040
644 HAIR COLOUR CHANGES 50 0.0040
645 DYSPNOEA 2272 0.0040
646 MENTAL DISORDER 174 0.0040
647 LUNG INFECTION 62 0.0040
648 PERICARDIAL EFFUSION 92 0.0040
649 RHINORRHOEA 257 0.0040
650 SKIN LESION 109 0.0040
651 FACE OEDEMA 67 0.0040
652 DYSSTASIA 116 0.0040
653 PRODUCT ADMINISTRATION ERROR 80 0.0040
654 THYROID DISORDER 61 0.0040
655 CHOLECYSTECTOMY 45 0.0039
656 HYPOKINESIA 57 0.0039
657 GAIT INABILITY 131 0.0039
658 HEPATIC STEATOSIS 73 0.0039
659 DRUG INTOLERANCE 378 0.0039
660 DISORIENTATION 155 0.0039
661 BLINDNESS 159 0.0039
662 HEAD DISCOMFORT 69 0.0039
663 BLOOD PRESSURE SYSTOLIC INCREASED 76 0.0039
664 MUSCLE SPASMS 714 0.0039
665 INJECTION SITE EXTRAVASATION 48 0.0039
666 GASTRITIS 102 0.0039
667 CHOLELITHIASIS 127 0.0039
668 SWELLING FACE 252 0.0039
669 CHOLECYSTITIS 46 0.0039
670 MUSCULOSKELETAL STIFFNESS 338 0.0039
671 PULMONARY FIBROSIS 74 0.0039
672 TOOTH EXTRACTION 48 0.0039
673 BALANCE DISORDER 333 0.0038
674 PARAESTHESIA 606 0.0038
675 SKIN REACTION 54 0.0038
676 URTICARIA 641 0.0038
677 BREAST CANCER METASTATIC 41 0.0038
678 BEDRIDDEN 50 0.0038
679 HYPERSOMNIA 109 0.0038
680 DECREASED ACTIVITY 41 0.0038
681 SNEEZING 85 0.0038
682 MUSCLE ATROPHY 48 0.0038
683 PERIPHERAL COLDNESS 52 0.0038
684 SURGERY 222 0.0038
685 ALTERED STATE OF CONSCIOUSNESS 82 0.0038
686 DECREASED APPETITE 879 0.0038
687 DEEP VEIN THROMBOSIS 242 0.0037
688 ADRENAL INSUFFICIENCY 45 0.0037
689 FEEDING DISORDER 75 0.0037
690 THROAT TIGHTNESS 100 0.0037
691 IMPAIRED DRIVING ABILITY 42 0.0037
692 PHOTOSENSITIVITY REACTION 61 0.0037
693 PERICARDITIS 62 0.0037
694 HAEMATURIA 126 0.0037
695 HYPERHIDROSIS 474 0.0037
696 TRANSIENT ISCHAEMIC ATTACK 124 0.0037
697 ABDOMINAL PAIN 855 0.0037
698 PRODUCT DOSE OMISSION IN ERROR 104 0.0037
699 FULL BLOOD COUNT DECREASED 74 0.0037
700 HIP FRACTURE 118 0.0037
701 SEDATION 96 0.0037
702 COGNITIVE DISORDER 171 0.0037
703 GINGIVAL BLEEDING 50 0.0037
704 POISONING 46 0.0037
705 PULMONARY ARTERIAL HYPERTENSION 53 0.0037
706 MEDICATION ERROR 203 0.0036
707 DRUG EFFECT LESS THAN EXPECTED 54 0.0036
708 OBESITY 58 0.0036
709 BONE DENSITY DECREASED 114 0.0036
710 INTENTIONAL PRODUCT MISUSE 318 0.0036
711 ERYTHEMA 745 0.0036
712 DEPRESSION 822 0.0036
713 INTENTIONAL DOSE OMISSION 103 0.0036
714 DIZZINESS 1796 0.0036
715 ARTHROPATHY 200 0.0036
716 HIP ARTHROPLASTY 55 0.0036
717 GAIT DISTURBANCE 687 0.0036
718 RECTAL HAEMORRHAGE 154 0.0036
719 PRODUCT PRESCRIBING ISSUE 78 0.0036
720 DERMATITIS 75 0.0036
721 ASPARTATE AMINOTRANSFERASE INCREASED 190 0.0036
722 C-REACTIVE PROTEIN INCREASED 130 0.0036
723 CORONARY ARTERY DISEASE 108 0.0036
724 IMMUNE SYSTEM DISORDER 47 0.0036
725 HYPERSENSITIVITY 660 0.0036
726 DIABETES MELLITUS 271 0.0036
727 MENTAL IMPAIRMENT 86 0.0035
728 EYELID OEDEMA 41 0.0035
729 THROAT IRRITATION 158 0.0035
730 PANCYTOPENIA 196 0.0035
731 BLOOD ALKALINE PHOSPHATASE INCREASED 87 0.0035
732 PRODUCT USE COMPLAINT 55 0.0035
733 RASH PRURITIC 188 0.0035
734 BONE PAIN 203 0.0035
735 RASH MACULO-PAPULAR 77 0.0035
736 ASTHENIA 1296 0.0034
737 PREGNANCY 69 0.0034
738 HAIR TEXTURE ABNORMAL 46 0.0034
739 METASTASES TO CENTRAL NERVOUS SYSTEM 44 0.0034
740 PRODUCT PREPARATION ERROR 70 0.0034
741 ARTHRALGIA 1416 0.0034
742 NO ADVERSE EVENT 612 0.0034
743 INTESTINAL OBSTRUCTION 127 0.0034
744 PALPITATIONS 394 0.0034
745 JOINT STIFFNESS 88 0.0034
746 METASTASES TO BONE 55 0.0033
747 AMNESIA 218 0.0033
748 SKIN CANCER 72 0.0033
749 PNEUMONITIS 91 0.0033
750 DRUG ABUSE 278 0.0033
751 RASH 1454 0.0033
752 ACTIVITIES OF DAILY LIVING IMPAIRED 66 0.0033
753 BLOOD BILIRUBIN INCREASED 90 0.0033
754 DEAFNESS 87 0.0033
755 HAEMOGLOBIN DECREASED 341 0.0033
756 HALLUCINATION 250 0.0033
757 GASTRIC ULCER 63 0.0033
758 RENAL DISORDER 154 0.0033
759 VISION BLURRED 453 0.0033
760 CONVULSION 188 0.0033
761 LACRIMATION INCREASED 99 0.0033
762 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 157 0.0033
763 POLLAKIURIA 136 0.0033
764 INFLAMMATION 168 0.0033
765 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 231 0.0032
766 BLOOD CREATININE INCREASED 212 0.0032
767 HYPOPHAGIA 83 0.0032
768 FLUID OVERLOAD 47 0.0032
769 MOBILITY DECREASED 232 0.0032
770 BLOOD TRIGLYCERIDES INCREASED 57 0.0032
771 PRODUCT PHYSICAL ISSUE 65 0.0032
772 MALAISE 1413 0.0032
773 DRUG INEFFECTIVE 4237 0.0032
774 CENTRAL NERVOUS SYSTEM LESION 44 0.0032
775 PARANOIA 55 0.0032
776 DIARRHOEA 2059 0.0032
777 CARDIAC FAILURE CONGESTIVE 256 0.0032
778 WEIGHT INCREASED 711 0.0032
779 TREATMENT FAILURE 263 0.0032
780 STEVENS-JOHNSON SYNDROME 70 0.0031
781 TOOTH LOSS 65 0.0031
782 DRY EYE 156 0.0031
783 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 633 0.0031
784 SENSORY DISTURBANCE 50 0.0031
785 ORTHOSTATIC HYPOTENSION 54 0.0031
786 DIALYSIS 44 0.0031
787 CARDIAC DISORDER 290 0.0031
788 INSOMNIA 825 0.0031
789 IMPAIRED WORK ABILITY 66 0.0031
790 NERVOUSNESS 161 0.0031
791 DISTURBANCE IN ATTENTION 166 0.0031
792 OSTEONECROSIS OF JAW 76 0.0031
793 MEMORY IMPAIRMENT 421 0.0031
794 ALANINE AMINOTRANSFERASE INCREASED 188 0.0031
795 CONDITION AGGRAVATED 931 0.0031
796 PLATELET COUNT DECREASED 323 0.0030
797 GENERAL PHYSICAL HEALTH DETERIORATION 349 0.0030
798 THROMBOCYTOPENIA 337 0.0030
799 PSYCHOMOTOR HYPERACTIVITY 50 0.0030
800 COORDINATION ABNORMAL 42 0.0030
801 SUBDURAL HAEMATOMA 43 0.0030
802 FEELING HOT 184 0.0030
803 DYSPEPSIA 295 0.0030
804 RASH PAPULAR 67 0.0030
805 HEPATIC CIRRHOSIS 56 0.0030
806 HYPERTHYROIDISM 43 0.0030
807 FLUSHING 301 0.0030
808 OVERDOSE 638 0.0030
809 PRURITUS 1135 0.0030
810 IMMUNODEFICIENCY 44 0.0029
811 JOINT SWELLING 356 0.0029
812 HAEMORRHAGE 308 0.0029
813 MYALGIA 500 0.0029
814 FEELING ABNORMAL 704 0.0029
815 MULTIPLE FRACTURES 48 0.0029
816 INCORRECT ROUTE OF DRUG ADMINISTRATION 104 0.0029
817 SKIN HAEMORRHAGE 43 0.0029
818 PLASMA CELL MYELOMA 113 0.0029
819 OSTEONECROSIS 95 0.0029
820 CARDIAC FAILURE 232 0.0029
821 ABDOMINAL DISCOMFORT 482 0.0029
822 NEUTROPHIL COUNT DECREASED 117 0.0029
823 RASH ERYTHEMATOUS 137 0.0029
824 KNEE ARTHROPLASTY 60 0.0028
825 RASH MACULAR 99 0.0028
826 ANGINA PECTORIS 81 0.0028
827 PELVIC PAIN 51 0.0028
828 PANIC ATTACK 102 0.0028
829 ABDOMINAL PAIN UPPER 576 0.0028
830 DELUSION 43 0.0028
831 HYPOCALCAEMIA 52 0.0027
832 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64 0.0027
833 THERAPEUTIC RESPONSE UNEXPECTED 123 0.0027
834 EYE DISORDER 90 0.0027
835 NEUTROPENIA 372 0.0027
836 FLATULENCE 155 0.0027
837 MIDDLE INSOMNIA 51 0.0027
838 WHITE BLOOD CELL COUNT DECREASED 296 0.0027
839 VISUAL IMPAIRMENT 338 0.0027
840 HAEMATEMESIS 69 0.0027
841 CEREBROVASCULAR ACCIDENT 458 0.0027
842 THERAPY INTERRUPTED 193 0.0027
843 EOSINOPHILIA 47 0.0027
844 MOVEMENT DISORDER 86 0.0027
845 SYSTEMIC LUPUS ERYTHEMATOSUS 95 0.0027
846 FOETAL EXPOSURE DURING PREGNANCY 217 0.0027
847 HOT FLUSH 200 0.0027
848 TRANSAMINASES INCREASED 59 0.0027
849 HEPATIC FAILURE 79 0.0026
850 AGEUSIA 65 0.0026
851 CEREBRAL HAEMORRHAGE 93 0.0026
852 ADVERSE DRUG REACTION 232 0.0026
853 HYPOACUSIS 111 0.0026
854 GASTROINTESTINAL HAEMORRHAGE 215 0.0026
855 RHEUMATOID ARTHRITIS 292 0.0026
856 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 47 0.0026
857 OCULAR HYPERAEMIA 121 0.0025
858 LIVER DISORDER 113 0.0025
859 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 43 0.0025
860 CRYING 92 0.0025
861 INTERNATIONAL NORMALISED RATIO INCREASED 72 0.0025
862 HYPERGLYCAEMIA 92 0.0025
863 SUICIDAL IDEATION 230 0.0025
864 THERAPEUTIC PRODUCT EFFECT DECREASED 112 0.0025
865 SYNOVITIS 45 0.0025
866 FEELING JITTERY 47 0.0025
867 ALOPECIA 484 0.0025
868 THIRST 44 0.0025
869 GLOSSODYNIA 55 0.0025
870 DYSGEUSIA 182 0.0024
871 DEMENTIA 68 0.0024
872 DRUG ERUPTION 43 0.0024
873 SKIN IRRITATION 111 0.0024
874 NEOPLASM PROGRESSION 84 0.0024
875 DRUG EFFECT DECREASED 130 0.0024
876 ISCHAEMIC STROKE 43 0.0024
877 INTENTIONAL OVERDOSE 154 0.0024
878 EMOTIONAL DISORDER 74 0.0024
879 DISEASE PROGRESSION 283 0.0024
880 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
881 INJECTION SITE SWELLING 182 0.0024
882 EYE SWELLING 88 0.0024
883 EPILEPSY 72 0.0024
884 SKIN FISSURES 46 0.0024
885 HOSPITALISATION 360 0.0023
886 GASTRIC DISORDER 80 0.0023
887 PROTEINURIA 44 0.0023
888 MUSCULOSKELETAL DISORDER 44 0.0023
889 BLOOD GLUCOSE DECREASED 111 0.0023
890 EYE IRRITATION 133 0.0023
891 WITHDRAWAL SYNDROME 97 0.0023
892 THINKING ABNORMAL 43 0.0023
893 FAECES DISCOLOURED 50 0.0023
894 ABDOMINAL PAIN LOWER 58 0.0023
895 MALIGNANT NEOPLASM PROGRESSION 234 0.0023
896 TYPE 2 DIABETES MELLITUS 76 0.0023
897 CHOKING 44 0.0023
898 HAEMATOCHEZIA 124 0.0022
899 RHABDOMYOLYSIS 93 0.0022
900 SKIN EXFOLIATION 188 0.0022
901 PRESCRIBED OVERDOSE 43 0.0022
902 INJECTION SITE MASS 82 0.0022
903 PSORIATIC ARTHROPATHY 90 0.0022
904 THERAPEUTIC RESPONSE DECREASED 133 0.0022
905 HYPOGLYCAEMIA 106 0.0022
906 MELAENA 48 0.0022
907 NEOPLASM MALIGNANT 145 0.0022
908 PSYCHOTIC DISORDER 64 0.0022
909 DEVICE DISLOCATION 94 0.0022
910 LACTIC ACIDOSIS 70 0.0022
911 ECZEMA 113 0.0022
912 DEPRESSED MOOD 114 0.0022
913 BLOOD CREATINE PHOSPHOKINASE INCREASED 62 0.0022
914 PRODUCT SUBSTITUTION ISSUE 122 0.0021
915 HEPATIC ENZYME INCREASED 144 0.0021
916 MOOD ALTERED 57 0.0021
917 THERAPEUTIC RESPONSE SHORTENED 69 0.0021
918 INJECTION SITE PRURITUS 139 0.0021
919 LABORATORY TEST ABNORMAL 61 0.0021
920 COMPLICATION OF DEVICE INSERTION 41 0.0021
921 INJECTION SITE PAIN 627 0.0020
922 DRUG EFFECT INCOMPLETE 74 0.0020
923 DEATH 1755 0.0020
924 TREATMENT NONCOMPLIANCE 110 0.0020
925 RASH GENERALISED 52 0.0020
926 INJECTION SITE ERYTHEMA 249 0.0020
927 NIGHTMARE 69 0.0020
928 PRURITUS GENERALISED 43 0.0020
929 PANCREATITIS 105 0.0020
930 IRRITABILITY 119 0.0020
931 EXTRAPYRAMIDAL DISORDER 49 0.0020
932 CARDIOVASCULAR DISORDER 50 0.0020
933 CEREBRAL INFARCTION 48 0.0020
934 PRODUCT DOSE OMISSION 128 0.0020
935 ILL-DEFINED DISORDER 117 0.0019
936 FREQUENT BOWEL MOVEMENTS 52 0.0019
937 DRUG ADMINISTRATION ERROR 59 0.0019
938 LEUKOPENIA 96 0.0019
939 AGGRESSION 96 0.0019
940 EYE PRURITUS 63 0.0019
941 DRY SKIN 248 0.0019
942 WRONG TECHNIQUE IN DRUG USAGE PROCESS 67 0.0018
943 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 54 0.0018
944 INCORRECT DOSE ADMINISTERED 419 0.0018
945 INJECTION SITE BRUISING 146 0.0018
946 INJECTION SITE REACTION 124 0.0018
947 MULTIPLE SCLEROSIS 86 0.0018
948 HEPATIC FUNCTION ABNORMAL 67 0.0018
949 LIVER INJURY 44 0.0018
950 CONTRAINDICATED PRODUCT ADMINISTERED 54 0.0018
951 MYOCARDIAL INFARCTION 311 0.0018
952 PRODUCT PRESCRIBING ERROR 42 0.0018
953 DEVICE ISSUE 154 0.0017
954 FEMUR FRACTURE 53 0.0017
955 PAIN OF SKIN 46 0.0017
956 HEPATITIS 43 0.0017
957 ACCIDENTAL EXPOSURE TO PRODUCT 172 0.0017
958 VAGINAL HAEMORRHAGE 72 0.0017
959 ADVERSE EVENT 149 0.0016
960 DEVICE LEAKAGE 69 0.0016
961 COMPLETED SUICIDE 132 0.0016
962 THERAPY CESSATION 80 0.0016
963 ABNORMAL DREAMS 43 0.0016
964 ABNORMAL BEHAVIOUR 61 0.0015
965 INTERSTITIAL LUNG DISEASE 74 0.0015
966 BLOOD GLUCOSE INCREASED 285 0.0015
967 LIVER FUNCTION TEST ABNORMAL 43 0.0015
968 SUICIDE ATTEMPT 88 0.0014
969 DRUG-INDUCED LIVER INJURY 45 0.0014
970 MULTIPLE SCLEROSIS RELAPSE 95 0.0014
971 EXTRA DOSE ADMINISTERED 55 0.0014
972 DRUG EXPOSURE DURING PREGNANCY 46 0.0014
973 DRUG WITHDRAWAL SYNDROME 116 0.0013
974 DISEASE RECURRENCE 61 0.0013
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 43 0.0013
976 ANGER 42 0.0012
977 DEVICE BREAKAGE 50 0.0012
978 INJECTION SITE HAEMORRHAGE 97 0.0012
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 86 0.0012
980 PSORIASIS 153 0.0012
981 COLITIS ULCERATIVE 52 0.0012
982 SKIN BURNING SENSATION 82 0.0011
983 LUNG NEOPLASM MALIGNANT 47 0.0011
984 DEVICE MALFUNCTION 79 0.0011
985 DERMATITIS ATOPIC 57 0.0011
986 DRUG DEPENDENCE 172 0.0011
987 DRUG DOSE OMISSION 174 0.0011
988 ACNE 73 0.0010
989 DEVICE DIFFICULT TO USE 63 0.0010
990 BREAST CANCER 85 0.0009
991 UNDERDOSE 66 0.0009
992 PRODUCT STORAGE ERROR 79 0.0009